Publication | Open Access
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade
37
Citations
28
References
2021
Year
Cancer ImmunosurveillancePd-1 Pathway BlockadeImmunologyImmune Checkpoint InhibitorNovel Therapeutic AntibodyImmunotherapyMedicineRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1